Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06375031
Status:
RECRUITING
Last Update Posted:
2024-05-21
First Post:
2024-04-16
Brief Title:
Comparison of HR011408 and NovoRapid in Subjects With Diabetics
Sponsor:
Jiangsu HengRui Medicine Co Ltd
Organization:
Jiangsu HengRui Medicine Co Ltd
Study Overview
Official Title:
Comparing Pharmacokinetics and Pharmacodynamics Between HR011408 and NovoRapid in Subjects With Diabetics- A Randomized Double-Blind Three-cycle Crossover Phase I Clinical Trial
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of the study is to compare the pharmacokinetics and pharmacodynamics between HR011408 and NovoRapid in Subjects with Diabetics
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None